Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise as nonsteroidal treatments for hair loss.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

A new method to make Finasteride is more cost-effective and yields 16%.

Certain drugs that block specific enzymes can help treat prostate diseases.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

A new method was developed to measure and assess the activity and inhibition of the enzyme steroid 5α-reductase.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

Muscles can make their own androgens, which may help muscle growth.

Methylation of the 5-AR2 gene may cause resistance to Finasteride in BPH patients.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

A new compound that could treat various androgen-related conditions was created and analyzed.

Testosterone increases seizure risk through its conversion to specific neurosteroids.

The methods accurately measured brain androgens, showing most 5α-androstane-3α,17β-diol comes from outside the brain, while androsterone is both transported and made in the brain.

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

5α-Reductase helps regulate hormone action in toad testes, especially during breeding season.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

Mutations in certain receptors can cause diseases and offer new treatment options.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

5α-reductase 2 is crucial for stress response in male rats.